Filter Results:
(1,253)
Show Results For
- All HBS Web
(1,253)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
Show Results For
- All HBS Web
(1,253)
- People (5)
- News (177)
- Research (922)
- Events (6)
- Multimedia (12)
- Faculty Publications (754)
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Pharmaceutical Industry; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- June 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (D)
By: Sandra J. Sucher and Stacy McManus
Supplements the (A) and (B) cases. View Details
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (D)." Harvard Business School Case 603-046, June 2003. (Revised October 2004.)
- June 1999 (Revised June 2000)
- Case
Eckerd Corporation
By: Michael E. Porter and John E. Kelleher
Describes the history and current situation in the retail pharmacy industry, including competition from new merchants and Internet drugstores. Eckerd, one of the top four drug chains, must decide how to position itself for the future. View Details
Keywords: Competition; Alignment; Supply and Industry; Pharmaceutical Industry; Pharmaceutical Industry
Porter, Michael E., and John E. Kelleher. "Eckerd Corporation." Harvard Business School Case 799-141, June 1999. (Revised June 2000.)
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers... View Details
Keywords: by Bill George
- 20 May 2013
- Op-Ed
Making America an Industrial Powerhouse Again
talent pool in the US biomedical field that is second to none. And the only way to get that talent is for companies-both domestic and foreign-to do their R&D here. That's why pharmaceutical and biotechnology companies from around the... View Details
- 06 Mar 2012
- First Look
First Look: March 6
century. It focuses especially on Beiersdorf, a pharmaceutical and skin care company in Germany. During World War I, the expropriation of its brands and trademarks revealed its vulnerability to political risk. Following the advent of the... View Details
Keywords: Sean Silverthorne
- July 1981 (Revised December 1984)
- Case
American Distilling Co. (B)
Fruhan, William E., Jr. "American Distilling Co. (B)." Harvard Business School Case 281-009, July 1981. (Revised December 1984.)
- February 2001
- Teaching Note
CVS: The Web Strategy TN
By: John A. Deighton
Teaching Note for (9-500-008). View Details
- 23 Jul 2001
- Research & Ideas
How Relationships are Building Biotech
on biotech companies in terms of securing resources. And if the top executives had a career background at a pharmaceutical and/or healthcare company—the companies considered "downstream" to biotech—so much the better. The IPO is... View Details
Keywords: by Martha Lagace & Mallory Stark
- 01 Apr 1999
- News
Q & A: Confronting New Technologies: When Doing Right Is Wrong
industries or certain segments of the pharmaceutical business. But in many other industries - financial services, education, and health care, for instance - this analytical model is proving extremely helpful in understanding what is... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
influenced the industry by proving that intellectual property could be monetized through alliances with big pharmaceutical partners, according to Pisano. Genentech cut its first deal with Eli Lilly in 1982 and new entrants were excited.... View Details
- 13 Jun 2005
- Research & Ideas
From Turf Wars to Learning Curves: How Hospitals Adopt New Technology
in many cases, perform identical procedures in two or more hospitals during the course of a given week. We have found that this movement has negative effects on the degree to which surgeons are able to leverage their prior experience to improve future performance. We... View Details
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
the scale and resources of the corporate lab with some of the intensity and urgency associated with the venture capital model, you have something that can be very, very strong," Lerner says. The book describes how, in 2008, the View Details
Keywords: by Carmen Nobel
- 05 Mar 2001
- What Do You Think?
Fine Coupling: Can Human Resource Management Learn from Supply Chain Management?
Productivity will improve as the alternation of job assignments eliminates the 'indispensable' worker." Connie Luthy says, "I have practiced 'Just-In-Time' hiring ... in the pharmaceutical industry.... I have advised my client... View Details
Keywords: by James Heskett
- Web
Innovating in Health Care - Course Catalog
services, AI, digital health, medical devices, biopharma, diagnostics, payment and delivery intermediaries, telemedicine, DTC and PBM pharmaceutical delivery, and SaMD. The course has a global focus with case studies set in Africa and the... View Details
- December 2021
- Case
Zoetis
By: David E. Bell, Damien McLoughlin and Natalie Kindred
- Web
Executive Education Courses - Institute For Strategy And Competitiveness
care as part of their business model Executives from health care insurance companies, government entities that pay for health care, or other payor organizations Leaders from pharmaceutical companies, medical device companies, or other... View Details
- 01 Dec 2020
- News
The Complete Package
school, she got a job in a hotel sales department and decided to defer her education. Two years later, Pfizer headhunted Chong. She didn’t know the number of chambers in the heart, she admitted during her interview with the pharmaceutical... View Details
Keywords: April White; entrepreneurship; sustainability; packaging; leadership; women; Manufacturing
- 13 Jun 2017
- First Look
First Look at New Research and Ideas, June 13
Efforts Pay Off? Dynamic Panel Data Methods Revisited By: Chung, Doug J., Byungyeon Kim, and Byoung Park Abstract—We estimate a sales response model to evaluate the short- and long-term value of pharmaceutical sales representatives'... View Details
Keywords: Sean Silverthorne